THOR Synthorx Inc

PLEASANTON, Calif., March 15 /PRNewswire-FirstCall/ -- Thoratec Corporation (NASDAQ:THOR), a world leader in products to treat cardiovascular disease, said today that it will be participating in the Lehman Brothers 10th Annual Global Healthcare Conference on Wednesday, March 21. Gary F. Burbach, president and chief executive officer, will provide an update on the company, beginning at 10:15 a.m., Eastern Daylight Time (7:15 a.m., Pacific Daylight Time). The presentation will be available through the conference website at http://cc.talkpoint.com/LEHM002/031907a_jw/default.asp?entity=Thoratec, and on the company's website at http://www.thoratec.com/. Thoratec is a world leader in therapies to address advanced-stage heart failure. The company's product lines include the Thoratec(R) VAD (Ventricular Assist Device) and HeartMate(R) LVAS (Left Ventricular Assist System) with more than 11,000 devices implanted in patients suffering from heart failure. Additionally, its International Technidyne Corporation (ITC) division supplies blood testing and skin incision products. Thoratec is headquartered in Pleasanton, California. For more information, visit the company's web sites at http://www.thoratec.com/ or http://www.itcmed.com/ TNR-437 DATASOURCE: Thoratec Corporation CONTACT: David Smith, Executive Vice President, Chief Financial Officer of Thoratec Corporation, +1-925-847-8600; or Neal Rosen of Kalt Rosen & Co., +1-415-397-2686 Web site: http://www.thoratec.com/

Copyright